| Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results M Martelli, L Ceriani, G Ciccone, U Ricardi, I Kriachok, B Botto, ... Journal of Clinical Oncology, JCO-24-01373, 2024 | | 2024 |
| Autologous Stem Cell Transplantation in HIVPositive and HIV-Negative Patients with Lymphoma: A Propensity Score Matched Comparative Analysis A Re, M Oberti, A Stabile, A Andreini, C Cattaneo, C Pagani, S Casari, ... Preprints, 2024 | | 2024 |
| Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection A Marchal, ET Cirulli, I Neveux, E Bellos, RS Thwaites, KMS Barrett, ... Human Genetics and Genomics Advances 5 (3), 2024 | | 2024 |
| Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre … A Pulsoni, S Ferrero, ME Tosti, S Luminari, A Dondi, F Cavallo, F Merli, ... The Lancet Haematology 11 (7), e499-e509, 2024 | 3 | 2024 |
| Romidepsin plus cyclophosphamide, doxorubicin, vincristine, and prednisone versus cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously … V Camus, C Thieblemont, P Gaulard, M Cheminant, RO Casasnovas, ... Journal of Clinical Oncology 42 (14), 1612-1618, 2024 | 4 | 2024 |
| Curative intent therapy for DLBCL in the elderly A Tucci, L Masina, S Luminari Leukemia & Lymphoma 65 (5), 560-569, 2024 | | 2024 |
| IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma A Conconi, A Chiappella, AJM Ferreri, A Stathis, B Botto, M Sassone, ... Blood advances 8 (6), 1541-1549, 2024 | 4 | 2024 |
| The role of baseline 2‐[18F]‐FDG‐PET/CT metrics and radiomics features in predicting primary gastric lymphoma diagnosis D Albano, A Calabrò, F Dondi, S Bagnasco, A Tucci, F Bertagna Hematological Oncology 42 (2), e3266, 2024 | 1 | 2024 |
| MYC rearrangements in HIV-associated large B-cell lymphomas: EUROMYC, a European retrospective study C Pagani, C Rusconi, A Dalla Pria, E Ravano, P Schommers, ... Blood Advances 8 (4), 968-977, 2024 | 1 | 2024 |
| 2-[18] F FDG PET/CT dissemination features in adult burkitt lymphoma Are predictive of outcome D Albano, A Calabrò, A Talin, F Dondi, C Pagani, A Tucci, G Treglia, ... Annals of Hematology, 1-9, 2024 | | 2024 |
| Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 D Matuozzo, E Talouarn, A Marchal, P Zhang, J Manry, Y Seeleuthner, ... Genome Medicine 16 (1), 6, 2024 | | 2024 |
| B cell receptor silencing reveals the origin of high-grade B cell lymphomas with MYC and BCL2 rearrangements P Sindaco, S Lonardi, G Varano, I Pietrini, G Morello, P Balzarini, ... bioRxiv, 2024.07. 13.603066, 2024 | | 2024 |
| Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized … M Ladetto, R Tavarozzi, M Zanni, A Evangelista, S Ferrero, A Tucci, ... Annals of Oncology 35 (1), 118-129, 2024 | | 2024 |
| Myeloid neoplasm occurrence during stable molecular remission of NPM1-mutated AML: are we facing secondary disease or AML relapse? C Giupponi, D Bertoli, E Borlenghi, C Cattaneo, T Zollner, L Masina, ... Blood Cancer Journal 13 (1), 194, 2023 | 2 | 2023 |
| SIE/Sies/GITMO Criteria in Elderly Patients with Acute Myeloid Leukemia (AML): Useful Also in the New Drug Era? a Multicentric Real-Life Study By the Hematological Network Rete … E Borlenghi, L Masina, M Frigeni, I Lotesoriere, A Molteni, M Fumagalli, ... Blood 142 (Supplement 1), 956-956, 2023 | 1 | 2023 |
| Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A … J Chen, M Labopin, T Pabst, X Zhang, E Jiang, A Tucci, J Cornelissen, ... Bone marrow transplantation 58 (12), 1322-1330, 2023 | 3 | 2023 |
| Copanlisib in Combination with Rituximab and Bendamustine for Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients: Results from the Phase II … PMM Frascione, M Novo, A Castellino, L Marcheselli, SD Dattoli, A Tucci, ... Blood 142, 1728, 2023 | | 2023 |
| Cryopreserved Versus Non-Cryopreserved Peripheral Blood Haematopoietic Stem Cells for Autologous Stem Cell Transplantation in Multiple Myeloma: A Comparative Analysis from the … BM Amine Sr, L Gras Sr, L Baaij III, L Koster III, B Carpenter, E Nicholson, ... Blood 142, 1034, 2023 | | 2023 |
| Deciphering the Immune Microenvironment in Waldenstrom's Macroglobulinemia A Sacco, V Desantis, J Celay, V Giustini, F Rigali, F Savino, M Cea, ... Blood 142, 4690, 2023 | | 2023 |
| Survival Patterns of Non-Randomized Patients in the IELSG37 Study: Deauville Score 4 Is Not Necessarily Associated with Poor Outcome in Primary Mediastinal Lymphoma E Zucca, L Ceriani, AS Davies, G Ciccone, U Ricardi, A Di Rocco, ... Blood 142, 1718, 2023 | | 2023 |
